{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:42:14Z","timestamp":1790743334204,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T00:00:00Z","timestamp":1377216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40261-013-0117-6","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T09:52:18Z","timestamp":1377165138000},"page":"727-736","source":"Crossref","is-referenced-by-count":88,"title":["Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant"],"prefix":"10.1007","volume":"33","author":[{"given":"Grace","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid-Maria","family":"H\u00f8jer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe Klint","family":"Buchbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Serenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,23]]},"reference":[{"key":"117_CR1","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","volume":"54","author":"B Bang-Andersen","year":"2001","unstructured":"Bang-Andersen B, Ruhland T, J\u00f8rgensen M, et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2001;54:3206\u201321.","journal-title":"J Med Chem"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","volume":"340","author":"A M\u00f8rk","year":"2012","unstructured":"M\u00f8rk A, Pehrson A, Brennum LT, et al. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther. 2012;340:666\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4088\/JCP.11m07470","volume":"73","author":"N Henigsberg","year":"2012","unstructured":"Henigsberg N, Mahableshwarkar AR, Jacobsen P, Chen Y, Thase ME. A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder. J Clin Psychiatry. 2012;73:953\u20139.","journal-title":"J Clin Psychiatry"},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S1461145712000727","volume":"16","author":"R Jain","year":"2013","unstructured":"Jain R, Mahableshwarkar A, Jacobson P, Chen Y, Thase ME. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5\u00a0mg vortioxetine in adults with major depressive disorder. Int J Neuropsychopharmacol. 2013;16:313\u201321.","journal-title":"Int J Neuropsychopharmacol"},{"key":"117_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1185\/03007995.2012.761600","volume":"29","author":"AR Mahableshwarkar","year":"2013","unstructured":"Mahableshwarkar AR, Jacobsen PL, Chen Y. A randomized, double-blind trial of 2.5\u00a0mg and 5\u00a0mg vortioxetine (LuAA21004) versus placebo for 8\u00a0weeks in adults with major depressive disorder. Curr Med Res Opin. 2013;29:217\u201326.","journal-title":"Curr Med Res Opin"},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003088-200342020-00004","volume":"42","author":"MT Donato","year":"2003","unstructured":"Donato MT, Castell JV. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet. 2003;42:153\u201378.","journal-title":"Clin Pharmacokinet"},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","volume":"35","author":"JH Lin","year":"1998","unstructured":"Lin JH, Lu AY. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet. 1998;35:361\u201390.","journal-title":"Clin Pharmacokinet"},{"key":"117_CR8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11317220-000000000-00000","volume":"48","author":"A Hisaka","year":"2009","unstructured":"Hisaka A, Kusama M, Ohno Y, et al. A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling. Clin Pharmacokinet. 2009;48:653\u201366.","journal-title":"Clin Pharmacokinet"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000319744","volume":"86","author":"R Schellander","year":"2010","unstructured":"Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2010;86:203\u201315.","journal-title":"Pharmacology"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/dmd.112.044610","volume":"40","author":"MG Hvenegaard","year":"2012","unstructured":"Hvenegaard MG, Bang-Andersen B, Pedersen H, et al. Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004. Drug Metab Dispos. 2012;40:1357\u201365.","journal-title":"Drug Metab Dispos"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1742-7843.2012.00886.x","volume":"111","author":"J Areberg","year":"2012","unstructured":"Areberg J, S\u00f8gaard B, H\u00f8jer AM. The clinical pharmacokinetics of Lu AA21004 and its major metabolite in healthy young volunteers. Basic Clin Pharmacol Toxicol. 2012;111:198\u2013205.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"117_CR12","first-page":"1113","volume":"49","author":"D Nilausen","year":"2009","unstructured":"Nilausen D, H\u00f8jer A-M, Bendahl L. Absorption, metabolism, and excretion of an oral dose of [14C]-Lu AA21004 50\u00a0mg in healthy men. J Clin Pharmacol. 2009;49:1113.","journal-title":"J Clin Pharmacol"},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00003088-200645100-00006","volume":"45","author":"HS Brown","year":"2006","unstructured":"Brown HS, Galetin A, Hallifax D, et al. Prediction of in vivo drug-drug interactions from in vitro data: factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4. Clin Pharmacokinet. 2006;45:1035\u201350.","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 1","key":"117_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003088-199500291-00007","volume":"29","author":"LL Moltke von","year":"1995","unstructured":"von Moltke LL, Greenblatt DJ, Schmider J, et al. Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology. Clin Pharmacokinet. 1995;29(suppl 1):33\u201344.","journal-title":"Clin Pharmacokinet"},{"key":"117_CR15","doi-asserted-by":"crossref","unstructured":"Zhou S, Yung Chan S, et al. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet. 2005;44:279\u2013304.","DOI":"10.2165\/00003088-200544030-00005"},{"key":"117_CR16","first-page":"1114","volume":"49","author":"Y Wang","year":"2009","unstructured":"Wang Y, Wojtkowski T, Hanson E, et al. An open-label, multiple-dose study in healthy adults to assess the drug interaction potential of Lu AA21004 using the Indiana cocktail. J Clin Pharmacol. 2009;49:1114.","journal-title":"J Clin Pharmacol"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11594710-000000000-00000","volume":"26","author":"E Spina","year":"2012","unstructured":"Spina E, Trifiro G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26:39\u201367.","journal-title":"CNS Drugs"},{"key":"117_CR18","unstructured":"Areberg J, Naik H, Chen G, Pedersen KB, Vakilynejad M. A population pharmacokinetic meta-analysis of vortioxetine (Lu AA21004) in healthy subjects. Poster presented at the 12th International Forum on Mood and Anxiety Disorders (IFMAD), Barcelona, Spain, November 7\u20139, 2012."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0117-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0117-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0117-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:31:09Z","timestamp":1715905869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0117-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,23]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0117-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,23]]}}}